{
  "meta": {
    "title": "Hemostatic_And_Antihemostatic_Mechanism",
    "url": "https://brainandscalpel.vercel.app/hemostatic-and-antihemostatic-mechanism-c5fbe0bc.html",
    "scrapedAt": "2025-11-30T11:20:02.279Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombopoietin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboplastin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">M-CSF</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which hormone regulates platelet count via negative feedback?</span></p>",
      "unique_key": "DT1320725",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320725,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Thrombopoietin (TPO) </strong>regulates platelet production via negative feedback.</p>\n<p><strong>Thrombopoietin (TPO):</strong></p>\n<ul>\n<li><strong>Source:</strong> Primarily <strong>liver</strong>, also the kidney.</li>\n<li><strong>Function:</strong> Stimulates <strong>megakaryopoiesis</strong> (development of megakaryocytes) and <strong>thrombopoiesis</strong> (platelet production) in the bone marrow.</li>\n<li><strong>Feedback Mechanism:</strong> Platelets themselves <strong>bind and internalise TPO</strong>.\n<ul>\n<li><strong>Low Platelets:</strong> Less TPO is bound/cleared, leading to higher free TPO levels, which stimulate more platelet production.</li>\n<li><strong>High Platelets:</strong> More TPO is bound/cleared, leading to lower free TPO levels, which reduces stimulation of platelet production. This is a classic negative feedback loop.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Prothrombin (Option A):</strong> This is a clotting factor (Factor II), a precursor to thrombin, involved in the coagulation cascade, not in the regulation of platelet count.</p>\n<p><strong>Thromboplastin (Option C):</strong> This is Tissue Factor (Factor III), which initiates the extrinsic pathway of blood coagulation, and is not involved in platelet count regulation.</p>\n<p><strong>M-CSF (Option D):</strong> This is a colony-stimulating factor that promotes the development of monocytes and macrophages, not platelets.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Thrombopoietin (TPO)</strong> is the primary humoral regulator of platelet production via a negative feedback mechanism involving platelet binding and clearance.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">ADP</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">PDGF</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Histamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which molecule is released from platelet alpha granules?</span></p>",
      "unique_key": "DT1320726",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320726,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Platelet-Derived Growth Factor (PDGF)</strong> is a key protein specifically found within <strong>alpha granules</strong>, playing crucial roles in wound healing and cell proliferation.</p>\n<p><strong>Platelet Granules:</strong></p>\n<ul>\n<li><strong>Alpha (&alpha;) Granules:</strong>\n<ul>\n<li><strong>Contents:</strong> Contain a wide range of proteins, including adhesion molecules, coagulation factors, and growth factors.</li>\n<li><strong>Examples:</strong>\n<ul>\n<li><strong>Platelet-Derived Growth Factor (PDGF)</strong> <strong>(Option C)</strong>: Stimulates cell proliferation, wound healing, and angiogenesis.</li>\n<li>Transforming Growth Factor-beta (TGF-&beta;)</li>\n<li>Fibronectin</li>\n<li>Von Willebrand Factor (vWF)</li>\n<li>Platelet Factor 4 (PF4)</li>\n<li>Fibrinogen</li>\n<li>Factor V</li>\n</ul>\n</li>\n<li><strong>Function:</strong> Involved in platelet adhesion, aggregation, and the promotion of wound healing and tissue repair.</li>\n</ul>\n</li>\n<li><strong>Dense (&delta;) Granules (or Delta Granules):</strong>\n<ul>\n<li><strong>Contents:</strong> Primarily contain non-protein molecules.</li>\n<li><strong>Examples:</strong>\n<ul>\n<li><strong>Serotonin</strong> (5-hydroxytryptamine, 5-HT) <strong>(Option A)</strong>: Potent vasoconstrictor and platelet aggregator.</li>\n<li><strong>ADP (Adenosine Diphosphate) (Option B)</strong>: Key platelet agonist, promoting further platelet aggregation.</li>\n<li>ATP (Adenosine Triphosphate)</li>\n<li>Calcium</li>\n<li>Magnesium</li>\n<li>Polyphosphates</li>\n</ul>\n</li>\n<li><strong>Function:</strong> Involved in rapid platelet activation and vasoconstriction.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Histamine (Option D)</strong> is primarily stored in mast cells and basophils, not platelets, which lack histamine-containing granules</p>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><strong>PDGF</strong> (platelet-derived growth factor) is secreted from <strong>alpha granules</strong> in the platelets.</li>\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases the platelet aggregation</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">It is secreted by neutrophils and monocytes</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases the production of thromboxane A2</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which functions are associated with platelet-activating factors?</span></p>",
      "unique_key": "DT1320727",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320727,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Platelet-activating factor (PAF)</strong> promotes <strong>platelet aggregation</strong>, is secreted by <strong>neutrophils/monocytes</strong>, and <strong>increases thromboxane A2 production </strong>via arachidonic acid release.</p>\n<p><strong>Platelet-Activating Factor (PAF):</strong></p>\n<ul>\n<li><strong>Nature:</strong> A phospholipid mediator.</li>\n<li><strong>Sources:</strong> Secreted by various cells, including activated <strong>platelets, neutrophils, monocytes, macrophages, endothelial cells</strong>, and mast cells in response to injury, inflammation, and allergic reactions. <strong>(Option B)</strong></li>\n<li><strong>Functions:</strong></li>\n<li><strong>Platelet Aggregation:</strong> A very potent direct aggregator of platelets.<strong> (Option A)</strong></li>\n<li><strong>Inflammatory Activity:</strong> Potent pro-inflammatory mediator, increasing vascular permeability, chemotaxis, and leukocyte adhesion.</li>\n<li><strong>Vasodilation/Vasoconstriction:</strong> Can cause both, depending on concentration and tissue.</li>\n<li><strong>Thromboxane A2 Production:</strong> Acts via a G protein-coupled receptor to activate phospholipase A2, leading to the release of arachidonic acid and subsequent increased production of arachidonic acid derivatives, including <strong>thromboxane A2</strong> (TxA2)<strong>,</strong> which is itself a potent vasoconstrictor and platelet aggregator. <strong>(Option C)</strong></li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Functions of Platelet-Activating Factor (PAF):</strong></p>\n<ul>\n<li>It helps in platelet aggregation</li>\n<li>It has an inflammatory activity</li>\n<li>It acts via a G protein-coupled receptor to increase the production of arachidonic acid derivatives, including thromboxane A2.</li>\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Sluggish blood flow</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin infusion</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Damage to the intima of blood vessels</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital absence of protein C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following mechanisms does not enhance the process of thrombosis?</span></p>",
      "unique_key": "DT1320728",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320728,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Slow Heparin infusion</strong> is an <strong>anticoagulant therapy</strong> that <strong>inhibits</strong> thrombosis by activating antithrombin III, which in turn inactivates several clotting factors. Therefore, it does not enhance thrombosis; rather, it prevents or reduces it.</p>\n<ul>\n<li><strong>Virchow's Triad:</strong> The three primary factors that contribute to thrombus formation are:\n<ul>\n<li><strong>Endothelial injury:</strong> Damage to the inner lining of blood vessels.</li>\n<li><strong>Abnormal blood flow:</strong> Stasis (sluggish flow) or turbulence. <strong>(Option A)</strong></li>\n<li><strong>Hypercoagulability:</strong> Alterations in blood coagulation that favour clotting.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Damage to the intima of blood vessels (Option C):</strong> This is a primary initiating event for thrombosis as it exposes procoagulant surfaces and triggers platelet activation and the coagulation cascade, thus enhancing thrombosis.</p>\n<p><strong>Congenital absence of protein C (Option D):</strong> Protein C is an anticoagulant. Its absence means that clotting factors V and VIII cannot be properly inactivated, leading to a procoagulant state that significantly enhances thrombosis.",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IV</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor XII</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor III</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor XIII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which clotting factor stabilizes fibrin?</span></p>",
      "unique_key": "DT1320729",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Factor XIII deficiency</strong> leads to bleeding due to <strong>unstable fibrin clots</strong>, highlighting its critical role.</p>\n<p><strong>Fibrin Formation &amp; Stabilization:</strong></p>\n<ul>\n<li><strong>Fibrinogen (Factor I):</strong> Converted to fibrin monomers by thrombin.</li>\n<li><strong>Thrombin (Factor IIa):</strong> Converts fibrinogen to fibrin monomers.</li>\n<li><strong>Fibrin Monomers:</strong> Form an initial, unstable clot.</li>\n<li><strong>Factor XIII (Fibrin-Stabilising Factor):</strong> Activated by thrombin (Factor XIIIa).\n<ul>\n<li><strong>Function:</strong> Catalyses <strong>covalent cross-links</strong> between fibrin monomers, stabilising the clot. Deficiency leads to bleeding from unstable clots.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Other Key Clotting Factors and Their Primary Roles:</strong></p>\n<ul>\n<li><strong>Factor I (Fibrinogen):</strong> Forms the fibrin clot.</li>\n<li><strong>Factor II (Prothrombin):</strong> Precursor to Thrombin (IIa).</li>\n<li><strong>Factor III (Tissue Factor/Thromboplastin):</strong> Initiates the <strong>extrinsic pathway</strong>. <strong>(Option C)</strong></li>\n<li><strong>Factor IV (Calcium Ions, Ca2+):</strong> Essential <strong>cofactor</strong> for many steps. <strong>(Option A)</strong></li>\n<li><strong>Factor V (Proaccelerin):</strong> Cofactor for Factor Xa.</li>\n<li><strong>Factor VII (Proconvertin):</strong> Activates Factor IX &amp; X in the extrinsic pathway.</li>\n<li><strong>Factor VIII (Antihemophilic Factor):</strong> Cofactor for Factor IXa (intrinsic pathway).</li>\n<li><strong>Factor IX (Christmas Factor):</strong> Intrinsic pathway component.</li>\n<li><strong>Factor X (Stuart-Prower Factor):</strong> Central tothe common pathway (forms prothrombinase).</li>\n<li><strong>Factor XI (Plasma Thromboplastin Antecedent):</strong> Activates Factor IX (intrinsic pathway).</li>\n<li><strong>Factor XII (Hageman Factor):</strong> Initiates the <strong>intrinsic pathway</strong> (contact activation). <strong>(Option B)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Factor XIII </strong>is unique in<strong> cross-linking</strong> and <strong>stabilising the fibrin clot.</strong></p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor XI</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor X</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a clotting disorder lacks a component of the prothrombinase complex. Which is not part of this complex?</span></p>",
      "unique_key": "DT1320730",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Factor XI</strong> is involved upstream in the <strong>intrinsic pathway of coagulation</strong>, but it is not a direct component of the prothrombin activator complex itself.</p>\n<ul>\n<li>The <strong>prothrombin activator complex</strong> (also known as the prothrombinase complex) is responsible for converting <strong>prothrombin</strong> (Factor II) into<strong> thrombin </strong>(Factor IIa).</li>\n<li>This complex is formed by activated Factor X (<strong>Factor Xa</strong>), activated Factor V (<strong>Factor Va</strong>), calcium ions (<strong>Factor IV</strong>), and phospholipid surfaces.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250821-68d5b2e1-3c79-4d0f-93a7-1b2e9d7f43a8.png\">\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Prothrombin activator complex </strong>consists of Factor Xa, Factor Va, Calcium, and a phospholipid surface.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Intact vascular endothelium</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Antithrombin III</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">High velocity of circulation</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following mechanisms helps in prevention of formation of clot?</span></p>",
      "unique_key": "DT1320731",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Clot prevention is aided by <strong>intact endothelium</strong> (which releases anticoagulants like prostacyclin), <strong>antithrombin III</strong> (which inhibits thrombin and clotting factors), and <strong>high blood flow velocity</strong> (which prevents local accumulation of clotting factors).</p>\n<p><strong>Antithrombotic Mechanisms (Preventing Clot Formation):</strong></p>\n<ul>\n<li>These are crucial to prevent pathological thrombosis while allowing for normal hemostasis at sites of injury.\n<ul>\n<li><strong>Intact Vascular Endothelium (Option A):</strong>\n<ul>\n<li>Physical barrier prevents collagen/tissue factor exposure.</li>\n<li>Produces anti-platelet agents (NO, prostacyclin).</li>\n<li>Produces anticoagulants (heparan sulfate, thrombomodulin-Protein C pathway, TFPI).</li>\n<li>Produces fibrinolytic agents (t-PA).</li>\n</ul>\n</li>\n<li><strong>Antithrombin III (ATIII) (Option B):</strong>\n<ul>\n<li>Circulating protease inhibitor (liver-derived).</li>\n<li>Inactivates thrombin (IIa) and Factor Xa (primary targets).</li>\n<li>Activity is greatly enhanced by heparin.</li>\n</ul>\n</li>\n<li><strong>Normal (High) Velocity of Circulation (Blood Flow) (Option C):</strong>\n<ul>\n<li>Washes away activated clotting factors and prevents their accumulation.</li>\n<li>Reduces platelet-platelet and platelet-vessel wall contact.</li>\n<li>Opposes stasis (a pro-thrombotic factor).</li>\n</ul>\n</li>\n<li><strong>Protein C System:</strong> (Protein C &amp; S) inactivates Factors Va &amp; VIIIa.</li>\n<li><strong>Fibrinolytic System:</strong> (Plasminogen &rarr; Plasmin by t-PA/u-PA) breaks down fibrin clots</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IX</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VII</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old male with prolonged bleeding is diagnosed with Christmas disease. Which clotting factor is deficient?</span></p>",
      "unique_key": "DT1320732",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Christmas disease</strong>, also known as <strong>Haemophilia B</strong>, is a congenital bleeding disorder caused by a deficiency of <strong>Factor IX</strong>.</p>\n<ul>\n<li><strong>Hemophilias (X-linked Recessive Bleeding Disorders):</strong>\n<ul>\n<li><strong>Haemophilia A:</strong> Deficiency of <strong>Factor VIII</strong> (Antihemophilic Factor).</li>\n<li><strong>Haemophilia B (Christmas Disease):</strong> Deficiency of <strong>Factor IX</strong> (Christmas Factor). <strong>(Option A)</strong></li>\n<li><strong>Haemophilia C:</strong> Deficiency of Factor XI (less severe, autosomal recessive).</li>\n</ul>\n</li>\n<li><strong>Other Genetic Bleeding Disorders (non-hemophilias):</strong>\n<ul>\n<li><strong>Factor VII deficiency (Hypoconvertinemia):</strong> Affects the extrinsic pathway. <strong>(Option C)</strong></li>\n<li><strong>Factor V deficiency (Parahemophilia):</strong> Affects the common pathway. <strong>(Option D)</strong></li>\n<li><strong>Von Willebrand Disease (vWD):</strong> Deficiency or defect in von Willebrand Factor, affecting platelet adhesion and Factor VIII stability. Most common inherited bleeding disorder.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Christmas disease</strong> is synonymous with <strong>Haemophilia B</strong> and is caused by <strong>Factor IX deficiency.</strong></li>\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">It is secreted from the endothelial cells of the cerebral microcirculation</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">It is direct anticoagulant molecule</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">It binds with thrombin and activates factor V and factor VIII</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">It binds with thrombin and activates the protein C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about Thrombomodulin is:</span></p>",
      "unique_key": "DT1320734",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Thrombomodulin</strong>, upon binding to thrombin,<strong> forms a complex </strong>that acts as a <strong>potent activator of Protein C</strong>, thereby initiating a crucial natural anticoagulant pathway.</p>\n<p><strong>Thrombomodulin (TM):</strong></p>\n<ul>\n<li><strong>Location:</strong>\n<ul>\n<li>Transmembrane glycoprotein found on the surface of most endothelial cells</li>\n<li>Not present in cerebral microcirculation <strong>(Option A)</strong></li>\n</ul>\n</li>\n<li><strong>Role:</strong>\n<ul>\n<li>Acts as an <strong>important anticoagulant modulator</strong></li>\n<li><strong>Not a direct anticoagulant</strong> itself <strong>(Option B)</strong></li>\n<li>Functions as a <strong>cofactor</strong> for activation of other anticoagulant proteins</li>\n</ul>\n</li>\n<li><strong>Mechanism of Action:</strong>\n<ul>\n<li><strong>Binds thrombin (Factor IIa):</strong> Forms a <strong>1:1 complex</strong></li>\n<li>This complex <strong>loses procoagulant activity</strong> and gains anticoagulant function</li>\n<li><strong>Activates Protein C</strong> <strong>(Option D)</strong></li>\n<li>Activated Protein C (with Protein S) degrades Factors Va and VIIIa, reducing clot formation<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318eb973f99-65ea-4ea7-aa12-560bcbca8730.jpg\"></li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>It binds with thrombin and activates factor V and factor VIII (Option C):</strong> Thrombin alone (not when bound to TM) activates Factor V and VIII.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Thrombin-thrombomodulin complex </strong>activates <strong>Protein C,</strong> shifting the thrombin's role from procoagulant to <strong>anticoagulant/fibrinolytic.</strong></li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">It activates the antithrombin III and acts as an anticoagulant</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">It lyses fibrin and fibrinogen to produce fibrin degradation products</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as calcium chelating agent</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">It has an antiplatelet action</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 51-year-old male with myocardial infarction receives streptokinase. How does streptokinase act to dissolve clots?</span></p>",
      "unique_key": "DT1320735",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320735,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Streptokinase </strong>primarily acts as a <strong>fibrinolytic (thrombolytic) agent </strong>by converting <strong>plasminogen into plasmin,</strong> which then directly <strong>lyses fibrin </strong>and <strong>fibrinogen </strong>to produce<strong> fibrin degradation products.</strong> This action effectively dissolves pre-formed clots, making it a crucial treatment in conditions like myocardial infarction, where a thrombus obstructs blood flow.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503187a33f78f-44e9-4b2e-b7f3-41b35c8ceaba.jpg\">\n<p><strong>Streptokinase:</strong></p>\n<ul>\n<li>Fibrinolytic/Thrombolytic agent.</li>\n<li>Bacterial enzyme (from Streptococcus species).</li>\n<li><strong>Mechanism of Action </strong>\n<ul>\n<li>Forms a complex with plasminogen.</li>\n<li>This complex activates free plasminogen into active <strong>plasmin</strong>.</li>\n<li><strong>Plasmin</strong> is the enzyme that directly breaks down (lyses) <strong>fibrin (clot component) and fibrinogen</strong>, yielding <strong>fibrin degradation products (FDPs)</strong>.</li>\n<li><strong>Clinical Use:</strong> Acute myocardial infarction (MI), pulmonary embolism, deep vein thrombosis (DVT) to dissolve existing clots.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options: </strong></p>\n<p><strong>Activates antithrombin III and acts as an anticoagulant (Option A):</strong> This is the mechanism of action for Heparin, not Streptokinase. Heparin enhances ATIII's inactivation of thrombin and Factor Xa.</p>\n<p><strong>Acts as a calcium chelating agent (Option C):</strong> Calcium chelating agents (e.g., EDTA, citrate) bind calcium ions, which are essential cofactors in coagulation. Streptokinase does not operate this way.</p>\n<p><strong>Acts as an antiplatelet action (Option D):</strong> Antiplatelet drugs (e.g., Aspirin, Clopidogrel) inhibit various aspects of platelet function (adhesion, activation, aggregation). While dissolving a clot will indirectly reduce platelet involvement, Streptokinase's primary action is not directly on platelets but on fibrinolysis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Streptokinase's </strong>primary function is<strong> fibrinolysis,</strong> achieved by activating plasmin to break down fibrin and fibrinogen.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein C</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein S</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboplastin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following factors is/are not vitamin K dependent?</span></p>",
      "unique_key": "DT1320736",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Thromboplastin </strong>(Factor III, also known as Tissue Factor) is <strong>not </strong>a<strong> vitamin K-dependent factor.</strong></p>\n<p><strong>Vitamin K and Its Role in Coagulation:</strong></p>\n<ul>\n<li><strong>Function of Vitamin K:</strong>\n<ul>\n<li>Essential for <strong>post-translational gamma-carboxylation</strong> of specific glutamic acid residues.</li>\n<li>This modification is <strong>necessary for activation</strong> of certain coagulation and anticoagulant proteins.</li>\n</ul>\n</li>\n<li><strong>Vitamin K-Dependent Factors:</strong>\n<ul>\n<li><strong>Clotting factors:</strong> Factor II (Prothrombin), VII, IX, X</li>\n<li><strong>Anticoagulant proteins:</strong> Protein C and Protein S</li>\n</ul>\n</li>\n<li><strong>Protein C: (Option A)</strong>\n<ul>\n<li>Synthesized in the liver.</li>\n<li>When activated:\n<ul>\n<li><strong>Inactivates Factors V and VIII</strong></li>\n<li><strong>Inhibits plasminogen activator inhibitor (PAI-1)</strong> &rarr; promotes plasmin formation</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Protein S: (Option B)</strong>\n<ul>\n<li>Acts as a <strong>cofactor</strong> for activated Protein C.</li>\n<li>Enhances the inactivation of Factors V and VIII.</li>\n</ul>\n</li>\n<li><strong>Prothrombin (Factor II): (Option C)</strong>\n<ul>\n<li>Converted to <strong>thrombin</strong> by <strong>prothrombin activator</strong>.</li>\n<li>Thrombin converts <strong>fibrinogen to fibrin</strong>, leading to <strong>clot formation</strong>.</li>\n</ul>\n</li>\n<li><strong>Thromboplastin (Factor III): (Option D)</strong>\n<ul>\n<li>Also called <strong>tissue factor</strong>.</li>\n<li><strong>Activates the extrinsic pathway</strong> of coagulation.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">A antigen\r\n\r\n</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">B antigen</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">D antigen</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">None of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the antigen marked with an arrow.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318ae78ab4f-693e-46b9-8a72-70f2a9494ace.jpg\"></span></p>",
      "unique_key": "DT1320737",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320737,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The structure on the left is the <strong>H antigen</strong>, made of a core sugar chain (G, A, G, G) with a terminal fucose (F). In the ABO blood group system, the <strong>A antigen</strong> is formed when <strong>N-acetylgalactosamine</strong> is added to this H antigen. The structure on the right, marked by the arrow, shows this additional sugar, indicating it is the <strong>A antigen</strong>.</p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318093750b0-6525-4319-95d5-a41ce09eb0cf.jpg\">\n<p><strong>ABO Blood Group System:</strong></p>\n<ul>\n<li><strong>ABO Basis:</strong> Determined by specific <strong>carbohydrate antigens (A and B)</strong> present on red blood cell (RBC) surfaces.</li>\n<li><strong>H Antigen:</strong>\n<ul>\n<li>Universal <strong>precursor</strong> for both A and B antigens.</li>\n<li>Present in <strong>all ABO blood types</strong>.</li>\n<li>Formed by adding a <strong>terminal fucose (F)</strong> to a precursor oligosaccharide.</li>\n</ul>\n</li>\n<li><strong>O Blood Group:</strong>\n<ul>\n<li>Individuals lack functional <strong>A and B transferases</strong>.</li>\n<li>Only the <strong>H antigen</strong> remains unmodified on RBCs.</li>\n</ul>\n</li>\n<li><strong>A Antigen (Option A):</strong>\n<ul>\n<li>Formed when a specific transferase (encoded by the <strong>A gene</strong>) adds <strong>N-acetylgalactosamine</strong> (represented by the top 'G' in the arrowed structure) to the H antigen.</li>\n</ul>\n</li>\n<li><strong>B Antigen (Option B):</strong>\n<ul>\n<li>Formed when a different transferase (encoded by the <strong>B gene</strong>) adds <strong>galactose</strong> to the H antigen.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>D Antigen (Option C):</strong> This refers to the Rh blood group system, which is separate from ABO. The D antigen is a protein, not a carbohydrate, and its presence determines Rh-positive or Rh-negative status.</p>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><strong>A antigen</strong> is formed by adding <strong>N-acetylgalactosamine</strong> to the <strong>H antigen</strong>.</li>\n<li><strong>B antigen</strong> is formed by adding <strong>galactose</strong> to the <strong>H antigen.</strong></li>\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">A agglutinogen</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">B agglutinogen</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">D agglutinogen</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is evaluated for blood group antigens. Which antigen is found only on RBCs and not on intestinal bacteria?</span></p>",
      "unique_key": "DT1320738",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The<strong> D agglutinogen (antigen) </strong>is found exclusively on the membrane of <strong>red blood cells </strong>(RBCs) and is<strong> not present </strong>on the surface of<strong> intestinal bacteria.</strong></p>\n<p><strong>ABO Blood Group Antigens (Agglutinogens):</strong></p>\n<ul>\n<li><strong>A agglutinogen (Antigen A):</strong> Found on RBC membranes and also present on some intestinal bacteria and in some foods. <strong>(Option A)</strong></li>\n<li><strong>B agglutinogen (Antigen B):</strong> Found on RBC membranes and also present on some intestinal bacteria and in some foods. <strong>(Option B)</strong></li>\n<li>Environmental exposure to A and B antigens explains the natural presence of anti-A and anti-B antibodies in individuals lacking the corresponding antigen on their RBCs.</li>\n</ul>\n<p><strong>Rh Blood Group Antigens:</strong></p>\n<ul>\n<li><strong>D agglutinogen (Antigen D):</strong> This antigen is found <strong>only</strong> on the membrane of <strong>red blood cells (RBCs)</strong>. It is <strong>not</strong> present in intestinal bacteria or in foods. <strong>(Option C)</strong></li>\n<li>Individuals who are <strong>Rh-negative</strong> (lacking the D antigen) do <strong>not</strong> naturally have <strong>anti-Rh antibodies</strong> until exposed to Rh-positive blood (e.g., via transfusion or during pregnancy).</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><strong>Antigen A</strong> and <strong>antigen B </strong>are found on the surface of <strong>red blood cell membranes</strong>. These antigens are also found on some <strong>intestinal bacteria</strong> and some foods.</li>\n<li><strong>Antigen D</strong> is found <strong>only</strong> on the <strong>membrane of RBCs.</strong></li>\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">O positive\r\n\r\n</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">AB positive</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">B positive</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">O negative</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old female is undergoing surgery. Blood group testing was done to identify her blood group as shown below. What is her blood group?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318ffedcce7-ce0b-45da-9366-c9dd812151cc.jpg\"></span></p>",
      "unique_key": "DT1320740",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The image shows agglutination with Anti-A, Anti-B, and Anti-D sera, indicating the presence of A, B, and Rh (D) antigens. Thus, the patient's blood group is <strong>AB positive</strong>.</p>\n<ul>\n<li><strong>Blood Grouping:</strong>\n<ul>\n<li><strong>Principle</strong>: Based on detecting specific <strong>antigens (agglutinogens)</strong> on RBC surfaces and corresponding <strong>antibodies (agglutinins)</strong> in plasma.</li>\n<li><strong>Agglutination</strong>: Occurs when RBC surface <strong>antigen reacts with its specific antibody</strong> in the antiserum, leading to visible clumping.</li>\n</ul>\n</li>\n<li><strong>ABO Blood Group System:</strong>\n<ul>\n<li><strong>Anti-A serum</strong>:\n<ul>\n<li>Contains anti-A antibodies.</li>\n<li><strong>Clumping &rarr; A antigen present</strong>.</li>\n</ul>\n</li>\n<li><strong>Anti-B serum</strong>:\n<ul>\n<li>Contains anti-B antibodies.</li>\n<li><strong>Clumping &rarr; B antigen present</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>ABO Results Interpretation:</strong>\n<ul>\n<li><strong>Clumping in Anti-A only</strong> &rarr; Blood Group <strong>A</strong></li>\n<li><strong>Clumping in Anti-B only</strong> &rarr; Blood Group <strong>B</strong></li>\n<li><strong>Clumping in both Anti-A and Anti-B</strong> &rarr; Blood Group <strong>AB</strong></li>\n<li><strong>No clumping in Anti-A or Anti-B</strong> &rarr; Blood Group <strong>O </strong></li>\n</ul>\n</li>\n<li><strong>Rh Blood Group System:</strong>\n<ul>\n<li><strong>Anti-D serum</strong>:\n<ul>\n<li>Contains anti-D antibodies.</li>\n<li><strong>Clumping &rarr; D (Rh) antigen present</strong></li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Rh Results Interpretation:</strong>\n<ul>\n<li><strong>Clumping in Anti-D</strong> &rarr; <strong>Rh-positive</strong> (e.g., A⁺, B⁺, AB⁺, O⁺)</li>\n<li><strong>No clumping in Anti-D</strong> &rarr; <strong>Rh-negative</strong> (e.g., A⁻, B⁻, AB⁻, O⁻)</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318b82d2b95-7df1-4d62-8917-6426a99f6b55.jpg\"><p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Clumping in Anti-A, Anti-B, and Anti-D indicates <strong>AB-positive blood group.</strong></li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">A +ve</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">O +ve</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">A -ve</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">B +ve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A boy with B +ve blood group is born to a mother with O +ve blood group. Which could be the father's blood group?</span></p>",
      "unique_key": "DT1320744",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320744,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>To determine the possible blood group of the father, we need to consider the ABO blood group system and the Rh factor separately.</p>\n<ol>\n<li><strong>Analyze the Child's and Mother's ABO Genotypes:</strong>\n<ul>\n<li>The boy has a <strong>B blood group</strong>. This means his ABO genotype is either IBIB or IBi.</li>\n<li>The mother has an <strong>O blood group</strong>. This means her ABO genotype is ii. Since the mother can only pass on an i allele to her child, the boy must have received the IB allele from his father.</li>\n</ul>\n</li>\n<li><strong>Determine the Father's Necessary ABO Contribution:</strong>\n<ul>\n<li>For the child to have an IB allele (and thus a B blood group, given the mother contributes an i), the father's ABO genotype must include at least one IB allele. This means the father's ABO blood group could be either B (IBIB or IBi) or AB (IAIB).</li>\n</ul>\n</li>\n<li><strong>Consider the Rh Factor:</strong>\n<ul>\n<li>The boy is <strong>Rh+</strong> (Rh+/Rh+ or Rh+/Rh&minus;).</li>\n<li>The mother is <strong>Rh+</strong> (Rh+/Rh+ or Rh+/Rh&minus;).</li>\n<li>If the mother is Rh+/Rh+, any father's Rh genotype can result in an Rh+ child.</li>\n<li>If the mother is Rh+/Rh&minus;, the father must contribute an Rh+ allele for an Rh+ child. An Rh+ father (as in option D) can certainly provide the Rh+ allele.</li>\n</ul>\n</li>\n</ol>\n<p>Considering both ABO and Rh, a father with B +ve blood group (IBIBRh+/Rh+, IBiRh+/Rh+, IBIBRh+/Rh&minus;, or IBiRh+/Rh&minus;) can pass on an IB allele and an Rh+ allele, making B +ve a possible blood group for the father.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>A) A +ve (Option A):</strong> An A blood group corresponds to genotypes IAIA or IAi. A father with an A blood group cannot contribute an IB allele to the child. Therefore, this option is incorrect based on ABO inheritance.</p>\n<p><strong>B) O +ve (Option B):</strong> An O blood group corresponds to the genotype ii. A father with an O blood group cannot contribute an IB allele to the child. Therefore, this option is incorrect based on ABO inheritance.</p>\n<p><strong>C) A -ve (Option C):</strong> An A blood group corresponds to genotypes IAIA or IAi. Similar to option A, a father with an A blood group cannot contribute an IB allele. The Rh- status is irrelevant because the primary exclusion is based on the ABO group. Therefore, this option is incorrect.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>To determine parental blood groups, analyze the child's and known parent's genotypes for both ABO and Rh systems.</li>\n<li>The child must inherit one allele from each parent.</li>\n<li>For a child with B blood group and an O blood group mother, the father <em>must</em> have an IB allele (i.e., B or AB blood group).</li>\n</ul>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombophlebitis</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute renal failure</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyrogenic reaction</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the hazards of mismatched blood transfusion from the following list.</span></p>",
      "unique_key": "DT1320746",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Acute renal failure</strong> is a significant hazard of mismatched blood transfusion.</p>\n<p><strong>Hazards of Mismatched Transfusion (Acute Hemolytic Transfusion Reaction - AHTR):</strong></p>\n<ul>\n<li>These are primarily due to antigen-antibody reactions leading to massive intravascular hemolysis.\n<ul>\n<li><strong>Excessive hemolysis (breakdown of RBCs)</strong>.</li>\n<li><strong>Hemolytic jaundice</strong> (due to excessive bilirubin formation from haemoglobin breakdown).</li>\n<li><strong>Acute renal failure</strong> (due to haemoglobin crystals obstructing renal tubules, leading to tubular necrosis).</li>\n<li><strong>Hepatic coma</strong> (in severe cases).</li>\n<li><strong>Circulatory shock</strong> (due to vasodilation and release of vasoactive substances).</li>\n<li>Disseminated Intravascular Coagulation (DIC) can also occur.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Hazards Even After Matched Transfusion (Non-Hemolytic or Delayed Reactions):</strong></p>\n<ul>\n<li>These are not directly caused by antigen-antibody mismatch against major blood groups.\n<ul>\n<li><strong>Circulatory overload</strong> (transfusion-associated circulatory overload - TACO).</li>\n<li><strong>Transmission of blood-borne infections</strong> (e.g., HIV, Hepatitis B/C).</li>\n<li><strong>Pyrogenic reaction</strong> (febrile non-hemolytic transfusion reaction - FNHTR). <strong>(Option C)</strong></li>\n<li><strong>Allergic reaction</strong> (mild to anaphylactic).</li>\n<li><strong>Hyperkalemia</strong> (from breakdown of stored RBCs).</li>\n<li><strong>Hypocalcemia</strong> (due to citrate toxicity, especially with massive transfusions). <strong>(Option D)</strong></li>\n<li><strong>Reduced tissue oxygenation</strong> (due to reduced 2,3-DPG in stored blood).</li>\n<li><strong>Hemosiderosis</strong> (iron overload from chronic transfusions).</li>\n<li><strong>Thrombophlebitis</strong> (local inflammation of a vein). <strong>(Option A)</strong></li>\n<li><strong>Air embolism</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><strong>Acute renal failure </strong>(due to haemoglobin crystals) is a direct and severe consequence of <strong>mismatched blood transfusion </strong>and <strong>massive hemolysis.</strong></li>\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">It can be very useful in planned surgery</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Hazards of mismatched transfusion can be reduced</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">The chances of transmission of infection are very less</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female undergoing elective surgery uses her own pre-donated blood. What is true about autologous transfusion?</span></p>",
      "unique_key": "DT1320749",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Autologous transfusion is useful in <strong>planned surgery</strong>, <strong>reduces mismatch risks</strong>, and <strong>minimizes infection transmission.</strong></p>\n<p><strong>Autologous Transfusion:</strong></p>\n<ul>\n<li>Collection and storage of a patient's own blood in anticipation of a surgical procedure for later reinfusion.</li>\n<li><strong>Advantages:</strong>\n<ul>\n<li><strong>Ideal for Elective Surgeries:</strong> Particularly useful when blood loss is anticipated; not suitable for emergency operations due to time needed for collection. <strong>(Option A)</strong></li>\n<li><strong>Eliminates Mismatched Transfusion Risk:</strong> Since the transfused blood is the patient's own, there's no risk of acute hemolytic or mismatched transfusion reactions. <strong>(Option B)</strong></li>\n<li><strong>Minimizes Risk of Transmitted Infections:</strong> Significantly lowers chances of HIV, Hepatitis B/C, syphilis, or malaria transmission.<strong> (Option C)</strong></li>\n<li><strong>Prevents Alloimmunization and Immunosuppression:</strong> Reduces immunologic complications associated with allogenic transfusion, including febrile or allergic reactions.</li>\n<li><strong>Beneficial for Rare Blood Groups:</strong> Especially advantageous for patients with uncommon blood types where compatible donor blood is hard to obtain.</li>\n<li><strong>Provides Fresh Whole Blood:</strong> Ensures availability of fresh, non-stored whole blood for optimal efficacy during transfusion.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Dd</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">DD</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">dd</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient's genetic workup shows no D antigen on RBCs. Which genotype does not result in Rh positive blood group?</span></p>",
      "unique_key": "DT1320753",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In the Rh blood group system, the <strong>D antigen</strong> is the most immunogenic and determines <strong>Rh positivity</strong>. The <strong>D gene is dominant</strong>, so individuals with genotypes <strong>DD or Dd</strong> are <strong>Rh positive</strong>. Only those with <strong>dd genotype</strong> (homozygous recessive) lack the D antigen and are thus <strong>Rh negative</strong>. Therefore, <strong>dd is the genotype that results in Rh negativity</strong>.</p>\n<p><strong>Rh Blood Group System:</strong></p>\n<ul>\n<li>Defined by the presence or absence of a set of antigens, primarily the D antigen, on the surface of red blood cells (RBCs).</li>\n<li><strong>Genes and Alleles:</strong> The Rh system involves multiple genes/alleles, including C, D, E, c, d, e.</li>\n<li><strong>D Antigen:</strong>\n<ul>\n<li>The <strong>D gene</strong> is the most clinically significant and immunogenic in the Rh system.</li>\n<li>It is a <strong>dominant gene</strong>.</li>\n<li>Located on the short arm of chromosome 1.</li>\n</ul>\n</li>\n<li><strong>Rh Positive Status:</strong> An individual is Rh positive if they possess at least one copy of the dominant D gene.\n<ul>\n<li>Genotypes: <strong>DD</strong> (homozygous dominant) or <strong>Dd</strong> (heterozygous). <strong>(Option A &amp; B)</strong></li>\n<li>This means they express the D antigen on their RBCs.</li>\n</ul>\n</li>\n<li><strong>Rh Negative Status:</strong>\n<ul>\n<li>An individual is Rh negative only if they possess two copies of the recessive<strong> 'd gene' (genotype dd)</strong>. <strong>(Option C)</strong></li>\n<li>The <strong>'d gene' </strong>is typically considered an amorph (non-functional allele) in this context, meaning it does not produce the D antigen.</li>\n<li>These individuals lack the D antigen on their RBCs.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Rh incompatibility is more dangerous than ABO in pregnancy</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Rh incompatibility can be treated by repeated blood tran</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">It can be prevented by giving anti-Rh antibody to the baby</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following is not true about Rh incompatibility:</span></p>",
      "unique_key": "DT1320755",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320755,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Rh incompatibility <strong>cannot be prevented by giving anti-Rh antibody to the baby</strong>. It is <strong>prevented by administering anti-Rh antibody (Rho(D) immune globulin)</strong> to the <strong>Rh-negative mother</strong>, typically during pregnancy and after delivery if the baby is Rh-positive.</p>\n<p><strong>Rh Incompatibility (HDFN):</strong></p>\n<ul>\n<li><strong>Pathophysiology:</strong> Occurs when an <strong>Rh-negative mother carries an Rh-positive fetus</strong>, and her immune system becomes sensitized to fetal red cells.</li>\n<li><strong>Complications in Fetus:</strong> Maternal <strong>IgG anti-D antibodies</strong> cross the placenta, leading to <strong>destruction of fetal RBCs</strong>, causing <strong>hemolytic anemia, jaundice, and hydrops fetalis</strong>.</li>\n<li><strong>Mechanism of Prevention:</strong> Anti-D antibody administered to the mother <strong>destroys fetal Rh-positive RBCs</strong> in maternal circulation <strong>before</strong> her immune system can recognize and react to them, thereby <strong>preventing sensitization</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Rh incompatibility is more dangerous than ABO in pregnancy (Option A):</strong> This statement is true. The IgG nature of anti-Rh antibodies allows them to cross the placenta easily, leading to more severe hemolytic disease in the fetus compared to ABO incompatibility.</p>\n<p><strong>Rh incompatibility can be treated by repeated blood transfusion (Option B):</strong> This statement is true. Exchange transfusions are a common treatment modality for severe HDFN in the neonate, aiming to remove sensitised RBCs and circulating maternal antibodies.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia\r\n</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta thalassemia major</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythroblastosis fetalis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An image from the peripheral blood smear of a fetus shows abnormal red blood cell morphology as shown below. Based on the findings and clinical context, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318e2ebb7dd-172c-49a0-bdc7-481f54743a38.jpg\"></span></p>",
      "unique_key": "DT1320758",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320758,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The blood picture shows numerous large, nucleated red blood cells, indicating intense erythropoiesis due to severe hemolysis. This is characteristic of <strong>Erythroblastosis fetalis (Hemolytic Disease of the Fetus and Newborn - HDFN)</strong>, where <strong>maternal antibodies destroy Rh-positive fetal RBCs</strong>, prompting premature release of erythroblasts from the bone marrow.</p>\n<p><strong>Erythroblastosis Fetalis (Hemolytic Disease of the Fetus and Newborn - HDFN):</strong></p>\n<ul>\n<li><strong>Cause:</strong> Typically Rh incompatibility (e.g., Rh-negative mother sensitised by Rh-positive fetus) or severe ABO incompatibility, leading to maternal antibodies attacking fetal/neonatal RBCs.</li>\n<li><strong>Pathophysiology:</strong> Maternal antibodies (usually IgG, like anti-D) cross the placenta, bind to fetal RBCs, and cause their hemolysis.</li>\n<li><strong>Clinical Presentation:</strong> Anaemia, jaundice, hepatosplenomegaly, and in severe cases, hydrops fetalis.</li>\n<li><strong>Characteristic Blood Picture:</strong> The body responds to severe hemolysis by rapidly producing and releasing immature red blood cells from the bone marrow. These immature RBCs are <strong>nucleated (erythroblasts)</strong> and can appear large, as seen in the image.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318e2ebb7dd-172c-49a0-bdc7-481f54743a38.jpg\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Sickle cell anaemia (Option A):</strong> In sickle cell anaemia, red blood cells become sickle-shaped under low oxygen conditions. The image does not primarily depict sickle-shaped cells; instead, it shows nucleated and large red blood cells.</p>\n<p><strong>Iron deficiency anaemia (Option B):</strong> In iron deficiency anaemia, red blood cells are typically microcytic (smaller than normal) and hypochromic (paler than normal) due to inadequate haemoglobin production. The cells in the image are described as large and nucleated, which is inconsistent with typical iron deficiency anaemia.</p>\n<p><strong>Beta thalassemia major (Option C):</strong> Beta thalassemia major shows nucleated RBCs due to severe erythropoiesis, but RBCs are microcytic and hypochromic, unlike the large, nucleated RBCs in erythroblastosis fetalis.&nbsp;</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Isograft</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Allograft</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Autograft</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Xenograft</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient receives a pig heart valve transplant. What type of graft is this?</span></p>",
      "unique_key": "DT1320760",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320760,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A transplant from a <strong>nonhuman animal to a human,</strong> or from an<strong> animal of one species to an animal of another species</strong>, is specifically known as a <strong>xenograft.</strong></p>\n<p><strong>Types of Grafts (Transplants):</strong></p>\n<ul>\n<li>Grafts are classified based on the genetic relationship between the donor and the recipient.\n<ul>\n<li><strong>Autograft:</strong> A transplant from <strong>one part of the same animal to another part</strong> of the same animal. This is the most successful type as there is no immune rejection (e.g., skin graft from thigh to arm on the same person). <strong>(Option C)</strong></li>\n<li><strong>Isograft:</strong> A transplant from <strong>one identical twin to another</strong>. This type has a very low chance of graft-versus-host reaction or rejection because identical twins have virtually identical genetic makeup. <strong>(Option A)</strong></li>\n<li><strong>Allograft:</strong> A transplant from <strong>one person to another person</strong> (not an identical twin) <strong>or from an animal to another animal of the same species</strong>. This is the most common type of human organ transplant and requires immunosuppressive drugs to prevent rejection. <strong>(Option B)</strong></li>\n<li><strong>Xenograft:</strong> A transplant from a <strong>nonhuman animal to a human</strong> or from an <strong>animal of one species to one of another species</strong>. This type faces the most severe immunological barriers due to vast species differences (e.g., a pig heart valve to a human). <strong>(Option D)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Transplant from a <strong>nonhuman animal to a human</strong> or from an <strong>animal of one species to one of another species</strong>, is known as a <strong>xenograft.</strong></li>\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}